Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy

Autor: Donald Kufe, Elena V. Efimova, Nikolai N. Khodarev, Eva Galka, Sean P. Pitroda, M.A. Beckett, Helena J. Mauceri, C R King, Samuel Hellman, Mitchell C. Posner, Hua Liang, Thomas E. Darga, Ralph R. Weichselbaum, Harold G. Sutton
Rok vydání: 2008
Předmět:
Zdroj: Cancer Gene Therapy. 16:373-381
ISSN: 1476-5500
0929-1903
DOI: 10.1038/cgt.2008.86
Popis: TNFerade is a radioinducible adenoviral vector expressing tumor necrosis factor-alpha (TNF-alpha) (Ad.Egr-TNF) currently in a phase III trial for inoperable pancreatic cancer. We studied B16-F1 melanoma tumors in TNF receptor wild-type (C57BL/6) and deficient (TNFR1,2-/- and TNFR1-/-) mice. Ad.Egr-TNF+IR inhibited tumor growth compared with IR in C57BL/6 but not in receptor-deficient mice. Tumors resistant to TNF-alpha were also sensitive to Ad.Egr-TNF+IR in C57BL/6 mice. Ad.Egr-TNF+IR produced an increase in tumor-associated endothelial cell apoptosis not observed in receptor-deficient animals. Also, B16-F1 tumors in mice with germline deletions of TNFR1,2, TNFR1 or TNF-alpha, or in mice receiving anti-TNF-alpha exhibited radiosensitivity. These results show that tumor-associated endothelium is the principal target for Ad.Egr-TNF radiosensitization and implicate TNF-alpha signaling in tumor radiosensitivity.
Databáze: OpenAIRE